Diplomat Pharmacy now filling ZINBRYTA prescriptions

Diplomat Pharmacy recently announced that it is now filling ZINBRYTA prescriptions.

ZINBRYTA (daclizumab), which was recently approved by the U.S. Food and Drug Administration (FDA), was developed to treat relapsing types of multiple sclerosis (MS) in adult patients.

"A relapse of any kind can cause a person to lose hope," Diplomat President Gary Kadlec said. "For people with relapsing multiple sclerosis, ZINBRYTA has the potential to restore that hope and make life a little easier."

MS, which affects the central nervous system, is unpredictable and often disabling as it disturbs the flow of information in the brain and communication between the brain and the rest of the body. Those who suffer from MS see symptoms that include numbness, tingling, blindness, paralysis and cognitive difficulties. Most people who are diagnosed with MS are between 20 and 50 years of age with approximately twice as many women diagnosed as men. These statistics are reported by the National Multiple Sclerosis Society.

ZINBRYTA, which is jointly manufactured by AbbVie and Biogen, is normally used on patients who have had adverse responses to two or more therapies designed to treat the disease.